Table 2.
Adverse events* for patients treated with Evo/Bev
| Adverse Event | Total | Grade 3/4 |
|---|---|---|
| Rash | 11 (47.8%) | 1 (4.3%) |
| Anal inflammation | 4 (17.4%) | 2 (8.7%) |
| Fatigue | 4 (17.4%) | 2 (8.7%) |
| Proctitis | 4 (17.4%) | 2 (8.7%) |
| Nausea | 4 (17.4%) | 1 (4.3%) |
| Stomatitis | 4 (17.4%) | 0 (0.0%) |
| Thrombocytopenia | 3 (13.0%) | 1 (4.3%) |
*By Common Terminology Criteria for Adverse Events 4.0.